A cost-effectiveness analysis of identifying Fusobacterium necrophorum in throat swabs followed by antibiotic treatment to reduce the incidence of Lemierre's syndrome and peritonsillar abscesses
- PMID: 22886057
- DOI: 10.1007/s10096-012-1715-6
A cost-effectiveness analysis of identifying Fusobacterium necrophorum in throat swabs followed by antibiotic treatment to reduce the incidence of Lemierre's syndrome and peritonsillar abscesses
Abstract
The main purpose of this paper was to estimate the cost per quality-adjusted life year (QALY) saved by identifying Fusobacterium necrophorum in throat swabs followed by proper antibiotic treatment, to reduce the incidence of Lemierre's syndrome and peritonsillar abscesses (PTA) originating from a pharyngitis. The second purpose was to estimate the population size required to indicate that antibiotic treatment has an effect. Data from publications and our laboratory were collected. Monte Carlo simulation and one-way sensitivity analysis were used to analyse cost-effectiveness. The cost-effectiveness analysis shows that examining throat swabs from 15- to 24-year-olds for F. necrophorum followed by antibiotic treatment will probably be less costly than most other life-saving medical interventions, with a median cost of US$8,795 per QALY saved. To indicate a reduced incidence of Lemierre's syndrome and PTA in Denmark, the intervention probably has to be followed for up to 5 years. Identifying F. necrophorum in throat swabs from 15- to 24-year-olds followed by proper antibiotic treatment only requires a reduction of 20-25 % in the incidence of Lemierre's syndrome and PTA to be cost-effective. This study warrants further examination of the effect of antibiotic treatment on the outcome of F. necrophorum acute and recurrent pharyngitis, as well as the effect on Lemierre's syndrome and PTA.
Similar articles
-
Fusobacterium necrophorum as the cause of recurrent sore throat: comparison of isolates from persistent sore throat syndrome and Lemierre's disease.J Infect. 2005 Nov;51(4):299-306. doi: 10.1016/j.jinf.2004.09.013. Epub 2004 Nov 5. J Infect. 2005. PMID: 16051369
-
Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey.Eur J Clin Microbiol Infect Dis. 2008 Sep;27(9):779-89. doi: 10.1007/s10096-008-0496-4. Epub 2008 Mar 11. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18330604 Free PMC article.
-
[Throat ache ans swelling of the neck: first symptoms of Lemierre's syndrome].Ned Tijdschr Tandheelkd. 2014 Mar;121(3):141-4. doi: 10.5177/ntvt.2014.03.13187. Ned Tijdschr Tandheelkd. 2014. PMID: 24684132 Dutch.
-
The role of Fusobacterium necrophorum in pharyngotonsillitis - A review.Anaerobe. 2016 Dec;42:89-97. doi: 10.1016/j.anaerobe.2016.09.006. Epub 2016 Sep 28. Anaerobe. 2016. PMID: 27693542 Review.
-
The long shadow of lemierre's syndrome.J Infect. 2017 Jun;74 Suppl 1:S47-S53. doi: 10.1016/S0163-4453(17)30191-3. J Infect. 2017. PMID: 28646962 Review.
Cited by
-
The first case report: diagnosis and management of necrotizing fusobacterium lung abscess via BALF next-generation sequencing.BMC Infect Dis. 2024 Feb 19;24(1):218. doi: 10.1186/s12879-024-09087-5. BMC Infect Dis. 2024. PMID: 38373919 Free PMC article.
-
Microarray identification of bacterial species in peritonsillar abscesses.Eur J Clin Microbiol Infect Dis. 2015 May;34(5):905-11. doi: 10.1007/s10096-014-2301-x. Epub 2014 Dec 30. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25547532
-
The aetiology of pharyngotonsillitis in adolescents and adults - Fusobacterium necrophorum is commonly found.Clin Microbiol Infect. 2015 Mar;21(3):263.e1-7. doi: 10.1016/j.cmi.2014.08.020. Epub 2014 Oct 13. Clin Microbiol Infect. 2015. PMID: 25658556 Free PMC article.
-
Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess.Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1733-9. doi: 10.1007/s10096-014-2130-y. Epub 2014 May 9. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24810966
-
What is the optimal strategy for managing primary care patients with an uncomplicated acute sore throat? Comparing the consequences of nine different strategies using a compilation of previous studies.BMJ Open. 2022 Apr 29;12(4):e059069. doi: 10.1136/bmjopen-2021-059069. BMJ Open. 2022. PMID: 35487741 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources